| |
| |
|
| Insider
Information: |
Rubin Paul D |
| Relationship: |
Sr. VP Clinical Dev. &... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
326,601 |
|
|
Indirect Shares
|
13,422 |
|
|
| Direct
Value |
$7,831,892 |
|
|
|
Indirect Value
|
$321,860 |
|
|
| Total
Shares |
340,023 |
|
|
| Total
Value |
$8,153,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
XOMA Corporation |
XOMA |
Sr. VP Clinical Dev. &... |
2016-03-22 |
326,601 |
2016-03-22 |
13,422 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-12-31 |
5 |
A |
$6.39 |
$1,956 |
D/D |
306 |
6,309 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-09-30 |
4 |
A |
$4.27 |
$1,958 |
D/D |
459 |
8,788 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-06-30 |
5 |
A |
$4.36 |
$2,058 |
D/D |
472 |
76,382 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-09-30 |
5 |
A |
$4.00 |
$2,052 |
D/D |
513 |
76,895 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2012-09-28 |
4 |
OE |
$3.51 |
$1,900 |
D/D |
542 |
1,203 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-06-28 |
4 |
OE |
$3.45 |
$1,955 |
D/D |
567 |
4,101 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-31 |
5 |
A |
$3.41 |
$2,057 |
D/D |
603 |
77,498 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2012-06-29 |
4 |
OE |
$2.83 |
$1,871 |
D/D |
661 |
661 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-10-18 |
4 |
AS |
$4.71 |
$3,511 |
D/D |
(746) |
8,788 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-10-18 |
4 |
OE |
$2.36 |
$1,761 |
D/D |
746 |
9,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-05-20 |
4 |
OE |
$2.36 |
$1,853 |
D/D |
785 |
9,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2012-12-31 |
4 |
OE |
$2.28 |
$1,899 |
D/D |
833 |
2,036 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-12-31 |
5 |
A |
$6.61 |
$5,867 |
I/I |
888 |
5,310 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2011-09-30 |
4 |
OE |
$1.66 |
$1,699 |
D/D |
1,022 |
1,022 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-03-31 |
5 |
A |
$4.95 |
$5,514 |
D/D |
1,114 |
94,608 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2012-03-30 |
4 |
OE |
$2.63 |
$3,234 |
D/D |
1,229 |
3,887 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-11-18 |
4 |
AS |
$4.08 |
$5,317 |
D/D |
(1,304) |
3,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-11-18 |
4 |
OE |
$2.36 |
$3,077 |
D/D |
1,304 |
4,838 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-03-28 |
4 |
OE |
$3.32 |
$4,967 |
D/D |
1,498 |
14,749 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-31 |
5 |
A |
$3.83 |
$6,019 |
I/I |
1,571 |
6,881 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-15 |
4 |
AS |
$4.63 |
$7,401 |
D/D |
(1,600) |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-12-15 |
4 |
OE |
$3.04 |
$4,864 |
D/D |
1,600 |
73,621 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2011-12-30 |
5 |
A |
$1.09 |
$1,787 |
D/D |
1,636 |
2,658 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-05-28 |
4 |
S |
$4.22 |
$7,533 |
D/D |
(1,785) |
83,601 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-05-28 |
4 |
S |
$3.60 |
$6,437 |
D/D |
(1,788) |
122,345 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
